Earnings History Data for Satsuma Pharmaceuticals, Inc. (STSA) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Satsuma Pharmaceuticals, Inc.

Satsuma Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It develops novel therapeutic products for the acute treatment of migraine. The company's product consists of STS101, which are in clinical stage. Satsuma Pharmaceuticals Inc. is based in San Francisco, United States.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
03-11-2022	AH	4:05 PM ET (Nov 3)	STSA	Satsuma Pharmaceuticals	158.00	-0.48	-0.57	0.00	Satsuma Pharmaceuticals GAAP EPS of -$0.48 [11/3/2022 5:20 PM]	4.57	-0.31 (-6.35%)	0.0	0.0 (0.00%)	2.51 - 8.08	240,682	100,000	0
Satsuma Pharmaceuticals GAAP EPS of -$0.48 [11/3/2022 5:20 PM] Satsuma Pharmaceuticals Reports Third Quarter 2022 Financial Results and Recent Business Highlights [Nov-03-22 04:05PM]
15-03-2022	AH		STSA	Satsuma Pharmaceuticals	125.00	-0.49	-0.47	0.00	Satsuma Pharmaceuticals GAAP EPS of -$0.49 [3/15/2022 5:00 PM]	3.80	0.01 (0.26%)	3.99	0.20 (5.28%)	3.75 - 7.48	31,498	64,283	100
Satsuma Pharmaceuticals Reports 2021 Full Year and Fourth Quarter Financial Results and Business Highlights [Mar-15-22 04:03PM]
10-08-2021	AH		STSA	Satsuma Pharma	160.00	-0.38	-0.38	0.00	Satsuma Pharmaceuticals EPS beats by $0.03 [8/10/2021 4:51 PM]	4.92	-0.10 (-1.99%)	0.0	0.0 (0.00%)	3.50 - 25.48	249,134	80,000	0
Satsuma Pharmaceuticals EPS beats by $0.03 [8/10/2021 4:51 PM] Satsuma Pharmaceuticals Reports Second Quarter 2021 Financial Results and Recent Business Highlights [Aug-10-21 04:05PM]
11-05-2021	AH		STSA	Satsuma Pharmaceuticals, Inc.	160.48	-0.48	-0.41	-0.68	Satsuma Pharmaceuticals EPS misses by $0.07 [5/11/2021 4:42 PM]	5.16	0.22 (4.45%)	4.94	0.0 (0.00%)	3.50 - 36.10	152,574	110,000	201
Satsuma Pharmaceuticals EPS misses by $0.07 [5/11/2021 4:42 PM] Why Earnings Season Could Be Great for Satsuma Pharmaceuticals (STSA) [May-10-21 09:28AM] Satsuma Pharmaceuticals Reports First Quarter 2021 Financial Results and Recent Business Highlights [May-11-21 04:01PM]
25-03-2021	AH		STSA	Satsuma Pharma	103.00	-0.72	-0.57	0.00	Satsuma Pharmaceuticals EPS misses by $0.19 [3/25/2021 5:14 PM]	5.70	-0.03 (-0.52%)	5.73	0.0 (0.00%)	3.50 - 36.10	72,846	220,000	209
Satsuma Pharmaceuticals EPS misses by $0.19 [3/25/2021 5:14 PM] Satsuma Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Business Highlights [Mar-25-21 05:00PM] Satsuma Posts Wider-Than-Feared Quarterly Loss [Mar-26-21 05:29AM]
10-11-2020	AH		STSA	Satsuma Pharmaceuticals, Inc.	70.37	-0.69	-0.67	-2.26	Satsuma Pharmaceuticals EPS beats by $0.02 [11/10/2020 4:42 PM]	4.01	0.0 (0.00%)	3.94	-0.07 (-1.75%)	3.50 - 36.10	386,771	319,867	3,073